论文信息 - Lack of evidence of amphotericin B toxicity in very low birth weight infants treated for systemic candidiasis. - 字舞流文

Lack of evidence of amphotericin B toxicity in very low birth weight infants treated for systemic candidiasis.

D. Waisman | J. Smyth | A. Kingo

[1] N. M. van Popele,et al. Antifungal agents in neonatal systemic candidiasis , 1995, Antimicrobial agents and chemotherapy.

[2] P. Sánchez,et al. Candida endocarditis: successful medical management in three preterm infants and review of the literature. , 1991, The Pediatric infectious disease journal.

[3] R. Kliegman,et al. Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. , 1990, The Journal of pediatrics.

[4] K. Butler,et al. Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates , 1990, The Pediatric infectious disease journal.

[5] R. Faix,et al. Mucocutaneous and Invasive Candidiasis Among Very Low Birth Weight (< 1,500 Grams) Infants in Intensive Care Nurseries: A Prospective Study , 1989, Pediatrics.

[6] P. Ferrieri,et al. Systemic Candidiasis in Very Low-Birth-Weight Infants (<1,500 Grams) , 1984, Pediatrics.

[7] A. Fanaroff,et al. Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology. , 1984, Pediatrics.

[8] A. Fanaroff,et al. Disseminated fungal infections in very low-birth-weight infants: therapeutic toxicity. , 1984, Pediatrics.

[9] A. Dalton,et al. Assessment of antifungal therapy in an 800-gram infant with candidal arthritis and osteomyelitis. , 1983, Pediatrics.